Elite Pharmaceuticals, Inc. Deferred Offering Costs
Elite Pharmaceuticals, Inc. (ELTP) had Deferred Offering Costs of $0 as of 2016-03-31, per its 10-K filed 2017-06-14.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2017-06-14
- 2016-03-31: Deferred Offering Costs $0.00; Deferred Offering Costs as first filed $204.40K.
- 2015-12-31: Deferred Offering Costs $207.94K.
- 2015-09-30: Deferred Offering Costs $211.49K.
- 2015-06-30: Deferred Offering Costs $215.03K.
| Period end | Deferred Offering Costs | Deferred Offering Costs as first filed |
|---|---|---|
| 2016-03-31 | $0.00 10-K · filed 2017-06-14 | $204.40K 10-K · filed 2016-06-15 |
| 2015-12-31 | $207.94K 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $211.49K 10-Q · filed 2015-12-30 | |
| 2015-06-30 | $215.03K 10-Q · filed 2015-12-30 | |
| 2015-03-31 | $218.58K 10-K · filed 2016-06-15 | |
| 2014-12-31 | $222.12K 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $225.67K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $229.21K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $232.76K 10-K · filed 2015-06-15 | |
| 2013-12-31 | $236.30K 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $239.84K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $243.39K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $246.93K 10-K · filed 2014-06-30 | |
| 2012-12-31 | $250.48K 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $254.02K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $257.57K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $261.42K 10-K · filed 2013-06-21 | |
| 2011-12-31 | $264.95K 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $268.49K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $272.02K 10-Q/A · filed 2011-08-19 | |
| 2011-03-31 | $275.55K 10-K · filed 2012-06-29 |